Study Comparing Bioavailability of Oral Formulations of Vabicaserin

The purpose of this study is to determine the absorption rate of four oral formulations of vabicaserin.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Schizophrenia Mental Disorders Schizophrenia Spectrum and Other Psychotic Disorders

Age range

18 year–50 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 1

Primary location

Philadelphia, Pennsylvania, 19148, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Healthy men aged 18-50 years.

Exclusion criteria

Any significant disease state.
History of drug or alcohol abuse within 1 year.
Abnormal liver function tests.

Treatment and study plan

vabicaserin

Drug

Primary outcomes

Assess the bioavailability of four oral formulations of vabicaserin.

Secondary outcomes

Obtain additional safety and tolerability data for vabicaserin in healthy male subjects.

Sponsors and collaborators

Lead sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Industry

Registry information

Official study title

A Randomized, Open-Label, Single-Dose, 4-Period Crossover, Comparative Bioavailability Study of 3 Sustained- Release Formulations and an Immediate- Release Formulation of Vabicaserin (SCA-136) in Healthy Subjects

Important dates

Study start: 2007
Study completion: 2007
First posted: Oct 10, 2007
Registry last updated: Dec 5, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed